Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

INTERIM REPORT, January–September 2018

Continued sales growth and improved earningsThird quarter of 2018 · Consolidated net sales increased by 20 percent to SEK 778 m (646), of which organic growth amounted to 3 percent. Acquisitions contributed by 12 percent and currency by 5 percent · Net sales in Products & Solutions amounted to SEK 575 m (457) and Installation Services to SEK 235 m (218) · EBITDA before items affecting comparability increased by 7 percent to SEK 103 m (96) · Operating profit (EBIT) before items affecting comparability increased by 5 percent to SEK 87 m (83) · Operating profit (EBIT) amounted

Apetit Plc’s financial reporting in 2019

Apetit Plc, Stock Exchange Release, 1 November 2018 at 9:00 a.m.Apetit will publish its Financial Statements Release, Half Year Financial Report and two Business Reviews in 2019 as follows: February 20, 2019 - Financial Statements Release for 2018May 8, 2019 - Business Review for January-March 2019August 16, 2019 - Half Year Financial Report for January-June 2019November 6, 2019 - Business Review for January-September 2019 The Annual Report for 2018 will be published during the week 10, 2019. Apetit's Annual General Meeting is planned to be held on Thursday, March 28, 2019.

NEXT Biometrics Receives New Order for Fingerprint Sensors to be Integrated into Point-of-Sale Terminals for India Market

OSLO, Nov. 1, 2018 -- NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, today announced the company has received an order for its fingerprint sensor modules from China-based Telpo (Telepower Communication Co. Ltd.). Telpo is a new customer and will incorporate the NEXT fingerprint module into point-of-sale (POS) terminals for the Indian market where the company is expanding its presence.                    Initial shipments of the sensor modules are expected later this quarter. Potential volumes for the application could be several hundred thousand

Monobank launches wearable payment

It is now possible to use Monobank's credit cards with Garmin Pay and their compatible sports watches." Monobank is a niche bank with digital forward leaning customers. They are innovative and like to stay up to date with the latest in fintech and payment solutions. Being able to offer a wearable payment solution is essential for us as a fintech bank, " says Bent Gjendem, CEO of Monobank. A key element of Monobank's strategy is to utilize its established position as digital niche bank to develop innovative fintech solutions for loans, deposits and credit cards that improve the customers'

Fabege increases its investment in Flemingsberg

Fabege acquires three properties close to the station in Flemingsberg from Vincero Fastigheter AB. Transfer of ownership for the properties Regulator 1, Batteriet 3 and Batteriet 4will take place 1 November 2018.Together with Huddinge municipality, will we now proceed with the plan for the area and its infrastructure. The area, with existing and planned infrastructure, is the natural hub of southern Stockholm. The total real estate value of the acquisitions amounts to approximately SEK 750m. -        “It is of course extremely exciting that we are up and running with this important

Apetit Plc’s Business Review 1 January – 30 September 2018: Favourable development continued in Food Solutions, weak crops are affecting Grain Trading’s profitability

Apetit Plc, Stock Exchange Release, 1 November 2018 at 8.30 a.m.Since 1 January 2018, Apetit has reported its first (Q1) and third (Q3) quarter results as Business Reviews. The Half-year Financial Report (Q2) and Financial Statements Bulletin (Q4) provide more extensive reporting and contain segment information. July–September 2018 · Net sales amounted to EUR 76.6 (74.4) million · Operational EBITDA was EUR 3.1 (3.0) million · Operational EBIT was EUR 1.7 (1.6) million January–September 2018 · Net sales amounted to EUR 209.1 (225.3) million · Operational EBITDA was

Interim statement January 1–September 30, 2018

Qt Group Plc Stock Exchange Release, November 1, 2018, at 8:00 a.m.Third quarter: Very strong growth in net sales continued (up 23.3 percent)July–September 2018: • Net sales increased by 23.3 percent year-on-year to EUR 10,748 thousand (8,718)*. At comparable exchange rates, net sales increased by 22.1 percent.• The operating result was EUR -1,045 thousand (-1,302).• The operating margin (EBIT %) was -9.7 percent (-14.9%).• Earnings per share were EUR -0.05 (-0.05).January–September 2018: • Net sales increased by 31.7 percent to EUR 34,452 thousand (26,152). At comparable

Interim Report Q3, 2018

NefIgArd Phase 3-study initiated according to plan“This quarter, the company went into execution mode with regards to the preparations related to our clinical Phase 3 study NefIgArd. We were excited to get going after receiving the necessary funds in July. We have been submitting requests for approval to ethic committees, negotiated contracts with clinics and continued to tie up the hundreds of ends required in order to initiate such a large, global study. With 19 countries and 149 sites, we believe that this is one of largest clinical studies to be managed out of Sweden today. Based on

Scania Interim Report January-September 2018

Summary of the first nine months of 2018 · Operating income amounted to SEK 10,153 m. (9,080) · Net sales increased by 11 percent to SEK 98,674 m. (89,111) · Cash flow amounted to SEK -134 m. (3,002) in Vehicles and Services · The period was affected by major disruptions in the supply chain resulting in negative cash flow · As from the 2018 financial year, the presentation of the income statement has been adjusted to align with Volkswagen Group’s (including comparative periods)Comments by Henrik Henriksson, President and CEO “Demand for the new truck range remained

Pihlajalinna Interim Report 1 January–30 September 2018 (9 months)

Pihlajalinna Plc     Interim Report     1 November 2018 at 8.00 a.m. Pihlajalinna Interim Report 1 January–30 September 2018 (9 months) Pihlajalinna’s profitability is improving, outlook unchanged Brief look at July–September: · Revenue amounted to EUR 116.3 (99.4) million – an increase of 17.0 per cent · EBITDA amounted to EUR 10.7 (9.1) million · Adjusted EBITDA was EUR 10.7 (9.0) million – an increase of 18.3 per cent · Operating profit (EBIT) was EUR 5.9 (5.5) million · Adjusted operating profit (EBIT) was EUR 5.9 (5.4) million – an increase of 10.8 per cent

Targovax ASA: Third quarter 2018 results

Oslo, Norway, 1 November 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2018 results.Targovax's management will host an online presentation for investors, analysts and the press at 08:45 CET. The presentation in Norwegian can be followed here , or at: https://www.facebook.com/AXExposure/videos/279295392691286/ An English version can be found on Targovax Events & Presentations 

Nel ASA: Third Quarter 2018 Results

(Oslo, November 1, 2018) Nel ASA (“Nel”) reported revenues in the third quarter of 2018 of NOK 116.0 million, up from NOK 111.7 million in the third quarter of 2017. Nel received several purchase orders during the quarter, recently announced the construction of the world’s largest electrolyzer manufacturing plant and reiterates a strong market outlook. “The third quarter of 2018 was a hectic quarter, reflecting both the momentum we are gaining across the world, as well as our ambitions for the future. This includes announcing the construction of the world’s largest electrolyzer plant in

NGEX SHARE CAPITAL AND VOTING RIGHTS UPDATE

VANCOUVER, BRITISH COLUMBIA--(October 31, 2018) /CNW/ – NGEx Resources Inc. ("NGEx" or the “Company”) (TSX: NGQ; NASDAQ Stockholm: NGQ), reports the following share capital and voting rights update in accordance with the Swedish Financial Instruments Trading Act. As a result of the issuance of 28,000 common shares pursuant to the terms of a previously announced credit facility, the number of issued and outstanding shares of the Company has increased to 227,659,153 common shares with voting rights as at October 31, 2018. Additional Information  This information is information that

Updated Share Capital and Voting Rights for BlackPearl

CALGARY, ALBERTA, Oct. 31, 2018 /CNW/ - BlackPearl Resources Inc. ("BlackPearl" or the "Company") (TSX: PXX) (NASDAQ Stockholm: PXXS) reports the following, in accordance with the Swedish Financial Instruments Trading Act: As a result of the exercise of stock options, as at October 31, 2018, the number of issued and outstanding shares of the Company is 337,263,507 common shares with voting rights. The information in this release is subject to the disclosure requirements of BlackPearl Resources Inc. under the Swedish Financial Instruments Trading Act. The information was submitted for

CONSORTIUM OF AFRICA OIL, DELONEX AND VITOL ANNOUNCES ACQUISITION OF PRODUCING ASSETS IN DEEPWATER NIGERIA

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES  All dollar amounts in this press release are USD unless otherwise indicated. VANCOUVER, October 31, 2018 /CNW/ A consortium led by Vitol and comprising Africa Oil Corp (“Africa Oil”) (25%), Delonex Energy Ltd. (“Delonex”) (25%) and Vitol Investment Partnership II Ltd. (“Vitol”) (50%), (collectively, the “Consortium”), is pleased to announce that it has entered into a Share Purchase Agreement (“SPA”) to acquire a 50% ownership interest in Petrobras Oil and Gas B.V. for $1.407 billion.

New Number of Shares and Votes in Tobii

The number of shares and votes in Tobii AB has increased by 132,852 as a result of exercise of warrants in accordance with the company’s incentive programs. Today, the last trading day of the month, there are in total 97,574,355 shares and votes in the company. After the increase, the share capital amounts to SEK 708,090.51. The increase in the number of shares is due to the exercise of warrants in accordance with the Company's incentive programs. This information is information that Tobii is obliged to make public pursuant to the Financial Instruments Trading Act. The information was

ExpreS2ion announces positive Phase I/IIa malaria vaccine trial results by The Jenner Institute, University of Oxford

Horsholm, Denmark, October 31 2018 – Today, ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that The Jenner Institute of the University of Oxford presents positive results from its Phase I/IIa clinical studies with their RH5.1 blood-stage malaria vaccine at a scientific meeting in New Orleans. The vaccine, developed and manufactured using ExpreS2ion’s ExpreS2 platform, was shown to be safe and it is the first vaccine to demonstrate a reduction in the parasite multiplication rate following a blood-stage controlled human malaria infection.In the results it is concluded, that RH5.1 is

Change of number of shares and votes in Instalco

Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 31 October 2018, there are in total 48,129,867 shares and votes in Instalco Intressenter AB (“Instalco” or the “Company”). The change in number of shares and votes in the Company is a result of the board of directors’ decision to issue in total 132,846 new

Follicum AB reports top-line data from First-in-Man Scalp Study with FOL-005 against hair loss

Follicum AB ("Follicum" or "Company"), a biotech company that develops new drugs in two areas, hair loss and diabetes, today reports top-line data from the first phase IIa study with FOL-005 for the treatment of hair loss on scalp in patients. The phase IIa study examined the safety and therapeutic effect of different doses of the drug candidate FOL-005, administered as injections into the scalp 3 times per week. The results confirmed that the treatment was safe with minimal side effects reported. Furthermore, increased hair growth was measured at the highest dose. Follicum will now follow up

Fellow Finance Oyj – Manager´s Transactions

Person subject to the notification requirementName: Antoni AirikkalaPosition: Other management IssuerName: Fellow Finance OyjLEI: 743700442EXD5CC8AT33 Notification type: INITIAL NOTIFICATIONReference number: 743700442EXD5CC8AT33_20181031111557_3 Transaction date: 2018-29-10Venue: noneInstrument type: SHAREISIN: FI4000348974Nature of the transaction: RECEIPT OF SHARE-BASED INCENTIVE OR REMUNERATION Transaction details (1) Volume: 11 000 Unit price: 7,587 EUR Aggregated transactions (1) Volume: 11 000 Volume weighted average price: 7,587 EUR Fellow

New direct route to Krabi from Stockholm Arlanda with Norwegian inaugurated

This winter, Swedes will be able to fly non-stop to another long-haul destination in Thailand. Today Norwegian started their direct service to the popular holiday destination of Krabi with two weekly departures from Stockholm Arlanda Airport. Thailand continues to be a favourite destination for Swedes. Norwegian already flies non-stop to Bangkok, and with the new destination of Krabi, Swedish travellers will have even more opportunities to fly directly to Thailand during the winter season. Bangkok is a year-round destination, while Krabi is a winter route. Krabi is located 900 km south

There are no items matching the current filter
There are no more items matching the current filter
Back to top